Hogan Lovells advised P-Cure in the authorization process.P-Cure, an Israeli med-tech company, in U.S. Food and Drug Administration (FDA) market clearance for a proton therapy system…
P-Cure’s FDA Market Authorization of New Proton Therapy Device for Cancer Treatment
